The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
Open accessAbstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, several studies have demonstrated that, although the overall response to MPH and amfetamine is similar, the response to each varies among individual patients, and non-response to one class of psychostimulant does not predict non-response to a second [32].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Tamoxifen for early breast cancer: an overview of the randomised trials
Abe, O., Bartholomeus, S., & Piccart, M. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,180
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,080
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Flagged first, then by citations
Research works printed but not linked: 1
- McDonagh M, Peterson K, Dana T, Thakurta S (2007) Drug Class Review on Pharamcologic Treatments for ADHD. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/adhd/pdfadhd.pdf . Accessed 27 September 2011. Oregon Health and Science University, Portland, Oregon
Cited by
Sorted by citations
Items 101–147 of 147
Gonda, X., Döme, P., Balogh, L., Baradits, M., & Réthelyi, J. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.108997 · Cited by 3
Digital health technologies for adults with ADHD: a scoping review
Schofield, F. J., Wilkie, S., Nielsen, E. E., Brigden, A., Jones, M. W., & Isotalus, H. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1746732 · Cited by 3
Stimulants: Definition, Pharmacology, Indications, Side Effects, and Treatment Strategies
Steinbuchel, P. H., & Greenhill, L. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_324 · Cited by 3
Boix, N. M., Collado-Valero, J. A., Roche, A. O., Navarro, M. R., García, S. F., Martínez, M., & Sória, I. N. (2023) · Revista de Discapacidad Clínica y Neurociencias · doi:10.14198/dcn.24671 · Cited by 2
Maletic, V., Mattingly, G. W., & Earnest, J. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2327533 · Cited by 2
The Utility of Biomarkers for Assessment and Intervention in Neurodevelopmental Disorders
Guldner, S., Ernst, J., Nees, F., & Holz, N. E. (2024) · Integrated science · doi:10.1007/978-3-031-76414-1_3 · Cited by 2
Treatment of affective dysregulation in ADHD with guanfacine: study protocol
Waltereit, J., Uhlmann, A., Tarassidis, C., Preuss, U., Roessner, V., & Waltereit, R. (2025) · Frontiers in Child and Adolescent Psychiatry · doi:10.3389/frcha.2025.1547672 · Cited by 2
Hallusinosis due to methylphenidate overdose in an eight-year-old child: a case report
Atabay, E., & Arman, A. R. (2017) · Marmara medical journal · doi:10.5472/mmjcr.2903.01 · Cited by 2
fNIRS-Based Clinical Assessment of ADHD Children
Monden, Y., Nagashima, M., Dan, H., Ikeda, T., Kyutoku, Y., Yamagata, T., & Dan, I. (2018) · InTech eBooks · doi:10.5772/intechopen.71835 · Cited by 3
Mazzetti, C., ter Huurne, N., Buitelaar, J. K., & Jensen, O. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.990929 · Cited by 2
Therapeutic Use of Dopamine Enhancers (Stimulants)
Zuddas, A., & Carucci, S. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_138-1 · Cited by 1
Dafny, N., Claussen, C. M., Frazier, E., & Liu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115938 · Cited by 1
van der Pal, Z., Geurts, H. M., Haslbeck, J. M. B., van Keeken, A., Bruijn, A. M., Douw, L., van Rooij, D., Franke, B., Buitelaar, J. K., Rommelse, N. N. J., et al. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-024-02610-8 · Cited by 2
Designing with Embodied Metaphors in XR for ADHD
Tazike, M. (2026) · International Conference on Tangible, Embedded, and Embodied Interaction (TEI) · doi:10.1145/3731459.3779041 · Cited by 1
Shah, S., Wei, H., Jayawardhana, J., Perri, M., Cobran, E. K., & Young, H. N. (2017) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12173 · Cited by 2
Actividad física y atención en escolares diagnosticados TDAH: revisión de estudios longitudinales.
Suárez-Manzano, S., Ruiz‐Ariza, A., López-Serrano, S., & López, E. J. M. (2018) · Innovación educativa · doi:10.15304/ie.28.4571 · Cited by 1
Management and treatment of attention-deficit/hyperactivity disorder
Zuddas, A., & Carucci, S. (2020) · doi:10.1093/med/9780198713005.003.0036 · Cited by 1
Psychopharmakologie in der Kinder- und Jugendpsychiatrie
Kölch, M. G. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-49289-5_69-1 · Cited by 1
Ramdin, C., Bikkina, R., Nelson, L. S., & Mazer-Amirshahi, M. E. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.01.042 · Cited by 1
Yuan, A., Claussen, C. M., Jones, Z., Tang, B., & Dafny, N. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02665-y · Cited by 1
Writers, A. M. (2014) · Drugs & Therapy Perspectives · doi:10.1007/s40267-014-0145-1
de Jaén, U., Suárez-Manzano, S., Ruiz‐Ariza, A., López-Serrano, S., & López, E. J. M. (2017) · MLS Educational Research · doi:10.29314/mlser.v1i1.21 · Cited by 1
SIDE EFFECTS OF MEDICATIONS USED TO TREAT ADHD IN BRAZIL’S PUBLIC HEALTH
Giffoni, S. D. A., de Castro, A. C., & Ciasca, S. M. (2018) · International Journal of Current Advanced Research · doi:10.24327/ijcar.2018.11881.2071
Attention Deficit Hyperactivity Disorder Medication Management: Where to Begin?
Siddiqi, S. U., & Dedlow, E. R. (2019) · Clinical Pediatrics · doi:10.1177/0009922819875530
Piacentino, D., Rossi, P. D., Kotzalidis, G. D., Maniscalco, I., Pompili, M., Giupponi, G., Hiemke, C., & Conca, A. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2740 · Cited by 1
Attention-Deficit/Hyperactivity Disorder and College Students
Lusby, C. M., & Kollins, S. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-56309-7_5
Parenting Adolescents with ADHD
Linnea, K. S., Solomon, D., & Mauras, C. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-62393-7_18
Attention Deficit Hyperactivity Disorder in Males
Coghill, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108646765.004
Self-citationThe D1 receptor agonist SKF38393 improves waiting impulsivity in a baseline dependent manner
Abdulkader, S., & Gigg, J. (2026) · Medical Research Archives · doi:10.1101/2023.07.15.549161
Neurodevelopmental Aspects of Behavioural Differences II. Autism Spectrum Disorder (ASD)
Stevenson, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-45787-6_10
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Walitza, S., Banaschewski, T., & Häge, A. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_12
Wendt‐Hornickle, E. (2024) · doi:10.1002/9781118975169.ch22
Teasley, M. L., & Teasley, B. R. (2024) · doi:10.1093/oso/9780197603413.003.0019
Psychopharmakologie in der Kinder- und Jugendpsychiatrie
Kölch, M. G. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-66744-6_69
Therapeutic Use of Dopamine Enhancers (Stimulants)
Zuddas, A., & Carucci, S. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_138
Adult ADHD: What It Is and How to Assess and Treat It
Martin, L. (2024) · Canadian Primary Care Today · doi:10.58931/cpct.2024.2337
Management and treatment of attention-deficit/hyperactivity disorder
Zuddas, A., Balia, C., & Carucci, S. (2020) · doi:10.1093/med/9780198713005.003.0036_update_001
Parenting Adolescents with ADHD
Linnea, K. S., Holding, E. Z., & Maurus, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-96950-8_20
Overholtzer, L. N., Bottenhorn, K. L., Karalunas, S. L., Peterson, B. S., & Herting, M. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-52107-4
Chopra, I., Horng, J., Krause, M., Sellinger, E. P., & Potenziano, J. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s575004
Jackson, E., Riley, T., & Overton, P. G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349512
Liu, J., Kang, B., Deng, W., Hao, Z., Yang, C., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819206
Salum, K. A., Hung, S.-H., Hsieh, M., Hsu, M., & Chang, C. (2026) · Drug Testing and Analysis · doi:10.1002/dta.70131
Anker, E., Bendiksen, B., Wergeland, G. J., & Thomsen, P. H. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1861616
Towards a Biopolitics of Psydiversity
Raud, R. (2026) · Philosophies · doi:10.3390/philosophies11050183
Metadata
- Authors
- Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L.
- Affiliations
- Norgine (United Kingdom) (GB)
- University of Dundee (GB)
- Montreal Children's Hospital (CA)
- Corresponding author
- Hodgkins, Paul
- Venue
- European Child & Adolescent Psychiatry
- Published
- 2012-07-05
- Volume
- 21
- Issue
- 9
- Pages
- 477-492
- ISSN
- 1018-8827 (ISSN-L)
- 1435-165X
- PMC
- PMC3432777
- OpenAlex
- W2117621614
- Cited by
- 147
- References
- 101
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 15 · 2023: 14 · 2022: 16 · 2021: 9 · 2020: 14 · 2019: 11 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 18 · 2013: 6
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- European Child & Adolescent Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, amphetamine, methylphenidate, stimulant medication, children and adolescents, treatment efficacy, drug safety, medication adherence, non-pharmacological treatment, personalized treatment
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Methylphenidate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
